Anti-Human IgE (ε-chain specific)−Peroxidase antibody produced in goat
SIGMA/A9667 - IgG fraction of antiserum, buffered aqueous solution
Synonym: Goat Anti-Human IgE (ε-chain specific)−HRP
MDL Number: MFCD00162430
Product Type: Chemical
antibody form | IgG fraction of antiserum |
antibody product type | secondary antibodies |
biological source | goat |
clone | polyclonal |
conjugate | peroxidase conjugate |
form | buffered aqueous solution |
Quality Level | 200 |
shipped in | dry ice |
storage temp. | −20°C |
target post-translational modification | unmodified |
technique(s) | direct ELISA: 1:2,000 |
dot blot: 1:10,000 (chemiluminescent) |
Application: | Anti-Human IgE (ε-chain specific)-Peroxidase antibody produced in goat has been used in IgE immunoblotting and in western blotting to analyse IgE binding efficiency. |
Disclaimer: | Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals. |
General description: | IgEs are glycoprotein antibodies that regulate immunological responses to allergies and infections. These immunoglobulins have been implicated in mediating Type I hypersensitivity reactions . Elevated IgE levels have been associated with hyper IgE syndrome and allergic asthma. Anti-Human IgE ε-chain specific-Peroxidase antibody binds to human IgE as against human IgG, and Bence Jones κ and λ myeloma proteins. |
General description: | Immunoglobulin E (IgE) belongs to the immunoglobulin family and consists of epsilon(ε) heavy chain in the constant (C) region. IgE has a monomeric structure with an extra domain in the constant region. |
Immunogen: | IgE purified from human myeloma serum |
Physical form: | Solution in 0.01 M phosphate buffered saline pH 7.4, containing 0.05% MIT |
Preparation Note: | Prepared by the two-step glutaraldehyde method described by Avrameas, S., et al., Scand. J. Immunol., 8, Suppl. 7, 7 (1978). |
Symbol | GHS08 |
Signal word | Danger |
Hazard statements | H317 - H334 |
Precautionary statements | P261 - P272 - P280 - P284 - P302 + P352 - P333 + P313 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Storage Temp. | −20°C |
UNSPSC | 12352203 |